Asia-Pacific Journal of Clinical Oncology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 15, 2017 Category: Cancer & Oncology Source Type: research
Prognostic significance of interim 18F ‐fluorodeoxyglucose positron emission tomography–computed tomography volumetric parameters in metastatic or recurrent gastric cancer
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 10, 2017 Category: Cancer & Oncology Source Type: research
---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 10, 2017 Category: Cancer & Oncology Source Type: research
Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi ‐institutional retrospective study
ConclusionsObesity was an independent predictor of BC patients requiring RC. Conversely, being underweight was associated with a favorable prognosis for BC patients. However, BMI was not an independent prognostic factor in patients with upper urinary tract cancer. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Yasukiyo Murakami, Kazumasa Matsumoto, Masaomi Ikeda, Takuji Utsunomiya, Takahiro Hirayama, Dai Koguchi, Daisuke Matsuda, Norihiko Okuno, Yoshinori Taoka, Akira Irie, Masatsugu Iwamura Tags: ORIGINAL ARTICLE Source Type: research
Treatment ‐related toxicities of immune checkpoint inhibitors in advanced cancers: A meta‐analysis
ConclusionsCI inhibitors have different toxicity profiles to chemotherapy. These findings are useful for patient counselling and planning of future trials. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Johnathan Man, Georgia Ritchie, Matthew Links, Sally Lord, Chee Khoon Lee Tags: ORIGINAL ARTICLE Source Type: research
High neutrophil ‐to‐lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy
ConclusionA high neutrophil‐to‐lymphocyte ratio at treatment initiation is a negative predictive marker for squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Sahan Chandrasekara, Sidney Davis, Peter Thomson, Andrew Haydon Tags: ORIGINAL ARTICLE Source Type: research
Cut ‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma
ConclusionThis study demonstrates a positive correlation between Ki‐67 index and overall survival in patients with GB. Percentage staining of Ki‐67 < 22% appears to predict for poorer survival in GB. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Eugene Wong, Najmun Nahar, Eric Hau, Winny Varikatt, Val Gebski, Thomas Ng, Jayasingham Jayamohan, Puma Sundaresan Tags: ORIGINAL ARTICLE Source Type: research
MAML1 and TWIST1 co ‐overexpression promote invasion of head and neck squamous cell carcinoma
ConclusionsSignificant correlation between MAML1 and TWIST1 in HNSCC was revealed. This study was the first report elucidating MAML1 clinical relevance in HNSCC. These new findings suggest an oncogenic role for concomitant expression of MAML1 and TWIST1 genes in HNSCC invasion and metastasis. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Sima Ardalan Khales, Ehsan Ebrahimi, Eisa Jahanzad, Sahar Ardalan Khales, Mohammad Mahdi Forghanifard Tags: ORIGINAL ARTICLE Source Type: research
Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer
ConclusionDespite limitations, this subgroup analysis suggests that ramucirumab monotherapy improves efficacy outcomes with a tolerable safety profile in EA patients with previously treated advanced gastric cancer. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Hyun Cheol Chung, Victor C. Kok, Rebecca Cheng, Yanzhi Hsu, Mauro Orlando, Charles Fuchs, Jae Yong Cho Tags: ORIGINAL ARTICLE Source Type: research
Immunomodulation characteristics by thermal ablation therapy in cancer patients
ConclusionsWe suggest a further immunomodulation therapy after thermal therapy for recovering a Th1‐ and Tc1‐dominant immune response for pursuing a better long‐term antitumor immunity. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Wuwei Yang, Wei Wang, Bing Liu, Baorang Zhu, Jing Li, Debao Xu, Yanli Ni, Li Bai, Guangxian Liu Tags: ORIGINAL ARTICLE Source Type: research
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single ‐arm, open‐label phase 2 study
ConclusionsAzacitidine was safe and effective in Chinese patients with HR‐MDS. Clinical outcomes were comparable to those for primarily Caucasian patients in the phase 3 AZA‐001 study. Cmax differences between Chinese and North American patients were not associated with differences in TEAE frequency or severity. No initial azacitidine dose adjustment is required for Chinese patients with HR‐MDS. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Xin Du, Yue ‐Yun Lai, Zhijian Xiao, Ting Liu, Yu Hu, Aining Sun, Xiao Li, Zhi‐Xiang Shen, Jie Jin, Li Yu, Eric Laille, Qian Dong, Stephen Songer, C.L. Beach Tags: ORIGINAL ARTICLE Source Type: research
Efficacy and safety of oxycodone/naloxone as add ‐on therapy to gabapentin or pregabalin for the management of chemotherapy‐induced peripheral neuropathy in Korea
ConclusionOxycodone/naloxone added to pregabalin or gabapentin provided additional pain relief and symptom control in Korean patients with CIPN, without clinically significant safety concerns. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Bong ‐Seog Kim, Jong‐Youl Jin, Jung Hye Kwon, In Sook Woo, Yoon Ho Ko, Suk‐Young Park, Hye‐Jeong Park, Jin Hyung Kang Tags: ORIGINAL ARTICLE Source Type: research
Clinical response to apatinib monotherapy in advanced non ‐small cell lung cancer
ConclusionsApatinib is effective and well tolerated in patients with advanced NSCLC, even at a dosage of 500 mg qd, and might offer a new option for the treatment of such patients with brain metastases. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Jianping Xu, Xiaoyan Liu, Sheng Yang, Xiangru Zhang, Yuankai Shi Tags: ORIGINAL ARTICLE Source Type: research
Prognostic significance of interim 18F ‐fluorodeoxyglucose positron emission tomography–computed tomography volumetric parameters in metastatic or recurrent gastric cancer
ConclusionMeasurement of metabolic decrease of volumetric parameters by interim PET/CT analysis is useful to determine the prognosis of patients with recurrent or metastatic AGC. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - December 1, 2017 Category: Cancer & Oncology Authors: Suk ‐young Lee, Hyo Jung Seo, Sungeun Kim, Jae Seon Eo, Sang Cheul Oh Tags: ORIGINAL ARTICLE Source Type: research
Visibility of an iron ‐containing fiducial marker in magnetic resonance imaging for high‐precision external beam prostate radiotherapy
ConclusionAlthough both markers were well visualized and can be recommended clinically, the results suggest that GA has some subtle advantages for quantitative visualization that could prove useful in certain situations of stereotactic body radiotherapy and intensity‐modulated radiotherapy. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 29, 2017 Category: Cancer & Oncology Authors: Osamu Tanaka, Hisao Komeda, Shigeki Hirose, Takuya Taniguchi, Kousei Ono, Masayuki Matsuo Tags: ORIGINAL ARTICLE Source Type: research
